Share Article

4 February 2020 – Ithaca, NY and London, UK – Zymtronix, developer of revolutionary enzyme immobilization technologies, and Tate & Lyle PLC (Tate & Lyle), a leading global provider of food and beverage ingredients and solutions, today announced a new partnership. This partnership includes an investment by Tate & Lyle in Zymtronix’s cutting edge enzyme immobilization platform that will enable the US-based company to drastically scale up its production.

Zymtronix’s enzyme immobilization platform helps to transform ingredient manufacturing by improving the productivity of biocatalysis. This is achieved through the immobilization of enzymes onto magnetic metamaterials to increase the efficiency and sustainability of enzyme-based industrial processes. The technology, originating from Cornell University (Ithaca, NY), has broad applications in the food & beverage, flavour & fragrances, pharmaceutical, chemical and agricultural industries. Tate & Lyle’s investment in Zymtronix will enable the company to improve and innovate upon their technology, with the goal of scaling up their platform to support process scale production. Zymtronix is initially working with Tate & Lyle to improve the use of enzymes in the production of certain ingredients and improve cost efficiency.

The two companies were brought together at Rabobank’s TERRA Accelerator 2019 in San Francisco, US. As part of the partnership, the retired Chief Technology Officer of Tate & Lyle, Michael Harrison, will join the board of Zymtronix, aiding the company with his wealth of experience within the food and beverage ingredients market.

“Consumers worldwide are looking for healthier food and drink, and we are proud to have the ingredients to help deliver just that. Improving lives for generations is at the heart of what we do, so we are excited to harness the power of Zymtronix’s enzyme immobilization platform, which will make our manufacturing processes more efficient. The platform also has the potential to accelerate our ability to make our ingredient solutions accessible to more consumers,” said Andrew Taylor, President of Innovation and Commercial Development, Tate & Lyle.

“We are delighted to announce Tate & Lyle as our first corporate partner. Their investment will enable us to further scale up our enzyme immobilization technology, advance our processes, develop our own target ingredients, and grow our team,” said Stéphane Corgié, Founder and CEO-CTO, Zymtronix.

About Tate & Lyle

Tate & Lyle is a global provider of solutions and ingredients for food, beverage and industrial markets. Tate & Lyle operates through two global divisions, Food & Beverage Solutions and Primary Products, supported by the Innovation and Commercial Development and Global Operations teams. Food & Beverage Solutions is focused on growth by building leading positions globally in the categories of beverages, dairy, and soups, sauces and dressings. Primary Products is focused on delivering steady earnings and generating cash. Food & Beverage Solutions consists of: Texturants, including speciality starches; Sweeteners, including low- and no-calorie sweeteners; and a Health and Wellness portfolio comprising mainly speciality fibres; and Stabilisers and Functional Systems, which are bespoke ingredient blends that ensure foods retain their structure. Primary Products consists of high-volume sweeteners, industrial starches and fermentation products (primarily acidulants). It also sells co-products from the corn milling process as animal nutrition. Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. In the year to 31 March 2019, Tate & Lyle sales totalled £2.8 billion. For more information, please visit or follow Tate & Lyle on Twitter or LinkedIn.

About Zymtronix

Zymtronix Catalytic Systems, Inc. (DBA Zymtronix, Inc.) is a biotech company formed in 2013 as a spin-off out of Cornell University. The company’s unique enzyme immobilization platform can improve any biocatalytic reaction involving single enzymes or multiple enzyme systems. The adaptable technology allows Zymtronix to offer solutions to various industries, including the production of food & beverage ingredients, flavor & fragrance, active pharmaceutical ingredients & fine chemicals. The founder, Stéphane Corgié, PhD (CEO-CTO) is joined by a dedicated and growing team of over 10 employees.

For more information about Zymtronix, please visit or follow Zymtronix on Twitter or LinkedIn

Media enquiries:


Sophie Mullany

Notch Communications

+44 (0) 161 818 9035

Tate & Lyle PLC:

Miriam Wilkens,

VP Global Communications,